Literature DB >> 2167230

Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart.

A D Fryer1, E E el-Fakahany, D B Jacoby.   

Abstract

Membrane preparations of guinea-pig lung (containing multiple muscarinic receptor subtypes) and heart (containing M2 receptors only) were incubated with either neuraminidase, parainfluenza virus (which contains neuraminidase), or virus plus 2,3-dehydro-2-deoxy-N-acetylneuraminic acid, a neuraminidase inhibitor. None of these treatments affected [3H]quinuclidinyl benzilate [( 3H]QNB) binding. In the lung and heart, carbachol displaced 0.2 nM [3H]QNB from two sites. After treatment with either neuraminidase or virus the high affinity site was shifted to the right, and carbachol displaced QNB from one site with low affinity in the lung. In contrast, neuraminidase or virus decreased the affinity of carbachol for both sites in the heart. The neuraminidase inhibitor completely blocked virus-induced changes in carbachol affinity in both tissues. These results suggest that parainfluenza virus decreases the affinity of agonists for some of the muscarinic receptors in the lung, and for all of the muscarinic receptors in the heart due to its neuraminidase activity, which results in removal of sialic acid. The decreased agonist affinity in the lung may be responsible for the increased vagally induced bronchoconstriction seen in viral respiratory infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167230     DOI: 10.1016/0014-2999(90)90244-z

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

1.  Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects.

Authors:  A G Fenech; M J Ebejer; A E Felice; R Ellul-Micallef; I P Hall
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Effect of respiratory tract viral infection on murine airway beta-adrenoceptor function, distribution and density.

Authors:  P J Henry; P J Rigby; J S Mackenzie; R G Goldie
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  Treatment with LPS plus INF-γ induces the expression and function of muscarinic acetylcholine receptors, modulating NIH3T3 cell proliferation: participation of NOS and COX.

Authors:  A J Español; M O Maddaleno; M G Lombardi; M Cella; P Martínez Pulido; M E Sales
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  Influence of respiratory tract viral infection on endothelin-1-induced potentiation of cholinergic nerve-mediated contraction in mouse trachea.

Authors:  M J Carr; R G Goldie; P J Henry
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

5.  Evidence for the absence of a functional role for muscarinic M2 inhibitory receptors in cat trachea in vivo: contrast with in vitro results.

Authors:  C R Killingsworth; M F Yu; N E Robinson
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

6.  Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.

Authors:  Gregory D Scott; Allison D Fryer
Journal:  Chem Immunol Allergy       Date:  2012-06-26

Review 7.  Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity.

Authors:  R W Costello; D B Jacoby; A D Fryer
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 8.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Virus- and interferon-induced loss of inhibitory M2 muscarinic receptor function and gene expression in cultured airway parasympathetic neurons.

Authors:  D B Jacoby; H Q Xiao; N H Lee; Y Chan-Li; A D Fryer
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  Potentiation by viral respiratory infection of ovalbumin-induced guinea-pig tracheal hyperresponsiveness: role for tachykinins.

Authors:  A R Ladenius; G Folkerts; H J van der Linde; F P Nijkamp
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.